Carlo Baldassarre Federici
Government, Health and Not for Profit
Biography
Carlo Federici is a lab researcher of Health Economics and Health Technology Assessment (HTA) at the Center for Research on Health and Social Care Management (CERGAS) of SDA Bocconi School of Management.
At SDA Bocconi Carlo teaches the Advanced Decision Modelling course at the Master of International Healthcare Management, Economics and Policy (MIHMEP) as well as several courses on HTA and economic evaluations of healthcare technologies. He conducted numerous research, training and consulting projects with Medtronic, Janssen, ABBOTT, Chiesi Farmaceutica, Assobiomedica, and many others. He contributed to several European research projects such as the H2020 projects MedtecHTA and COMED addressing the assessment of medical devices from different perspectives. In the past years, Carlo has also conducted several research activities with the Italian Ministry of Health on both reimbursement and regulatory aspects of medical technologies.
His research activities focus on the area of HTA and Health Policy Evaluation. His current research addresses both methodological aspects as well as applied case studies on decision analytical models to estimate cost-effectiveness of innovative health technologies as compared to other policy options. Other recent research areas include the identification of different dimensions of value when assessing health interventions, such as for example the real option value and insurance value of health technologies; the impact of technologies characteristics on organizational impact and operations management; or the study of performance-based risk sharing agreements between payers and technology developers (e.g., coverage with evidence development, payment by results etc.)
He is the author of numerous articles on the subject. His work has been published in Journal of Value in Health, PlosOne, Pharmacoeconomics, Health Policy among others. Carlo serves as a topic editor in the pharmaeconomics and outcome research area for the Journal Clinical Therapeutics. He is a member of the Italian Association of Health Economics (AIES) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Carlo earned a MSc in Health Economics from the University of York and he's actually a Ph.D. candidate at the University of Warwick.
Teaching domains
Markov Models
Economic Evaluations of Drugs
Meta-Analysis
Survival Analysis
Statistics for Clinical Studies
Latest publications
Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies
Health Policy, 27 March, 2021
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome
European Journal of Hospital Pharmacy, 2021, pp.ejhpharm-2020-002465
Performance-based risk-sharing agreements in renal care: current experience and future prospects
Expert Review Of Pharmacoeconomics & Outcomes Research, 5 March, 2021, pp.1-13
Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines
Pharmacoeconomics, 2020, vol.38, no. 10, pp.1055-1070
Impact of point of care ultrasound on the number of diagnostic examinations in elderly patients admitted to an internal medicine ward
European Journal of Internal Medicine, 2020, vol.79, pp.88-92
Early Cost-effectiveness Analysis of Electrochemotherapy as a Prospect Treatment Modality for Skin Melanoma
Clinical Therapeutics, 2020, vol.42, no. 8, pp.1535-1548.e2
